Melinta Therapeutics Inc (MLNTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,035 | -24,227 | -21,221 | -19,675 | -18,612 |
| Depreciation Amortization | 690 | 403 | 469 | 47 | 24 |
| Accounts receivable | -1,626 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,102 | -809 | 1,435 | 714 | 237 |
| Other Working Capital | 8,474 | -865 | 1,998 | 413 | -776 |
| Other Operating Activity | 953 | 2,391 | -996 | 947 | 1,814 |
| Operating Cash Flow | $-32,441 | $-23,107 | $-18,315 | $-17,553 | $-17,314 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -134 | -8 | -13 | -162 | -23 |
| Investing Cash Flow | $-134 | $-8 | $-13 | $-162 | $-23 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,238 | N/A | 15,000 | N/A | N/A |
| Debt Repayment | -238 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 54,470 | 78,324 | 70 | 8 | N/A |
| Other Financing Activity | -501 | -703 | -1,188 | 20,491 | 25,248 |
| Financing Cash Flow | $58,969 | $77,622 | $13,882 | $20,499 | $25,248 |
| Beginning Cash Position | 70,109 | 15,602 | 20,048 | 17,264 | 9,352 |
| End Cash Position | 96,503 | 70,109 | 15,602 | 20,048 | 17,264 |
| Net Cash Flow | $26,394 | $54,507 | $-4,446 | $2,784 | $7,912 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,441 | -23,107 | -18,315 | -17,553 | -17,314 |
| Capital Expenditure | -134 | -8 | -13 | -162 | -23 |
| Free Cash Flow | -32,575 | -23,115 | -18,328 | -17,715 | -17,336 |